|
DK319780A
(da)
*
|
1980-07-24 |
1982-01-25 |
Forenede Bryggerier As |
Fremgangsmaade til enzymatisk udskiftning af b-30 aminosyren i insuliner
|
|
DK353781A
(da)
*
|
1981-08-10 |
1983-02-11 |
Novo Industri As |
Fremgangsmaade til fremstilling af insulinderivater
|
|
AU551174B2
(en)
*
|
1981-09-15 |
1986-04-17 |
Nordisk Insulinlaboratorium |
Enzymatic preparation of human insulin or b-30 esters thereof
|
|
NL8201650A
(nl)
*
|
1982-04-21 |
1983-11-16 |
Akzo Nv |
Semisynthetische bereiding van humane insuline.
|
|
US4528134A
(en)
*
|
1982-12-27 |
1985-07-09 |
University Of Tn Research Corporation |
Method of separating A14 -125 I-insulin from heterogeneously labeled insulin molecules for biological studies
|
|
DK58285D0
(da)
*
|
1984-05-30 |
1985-02-08 |
Novo Industri As |
Peptider samt fremstilling og anvendelse deraf
|
|
PH25772A
(en)
*
|
1985-08-30 |
1991-10-18 |
Novo Industri As |
Insulin analogues, process for their preparation
|
|
DK257988D0
(da)
*
|
1988-05-11 |
1988-05-11 |
Novo Industri As |
Nye peptider
|
|
DE3844211A1
(de)
*
|
1988-12-29 |
1990-07-05 |
Hoechst Ag |
Neue insulinderivate, verfahren zu deren herstellung, ihre verwendung und eine sie enthaltende pharmazeutische zubereitung
|
|
DK134189D0
(da)
*
|
1989-03-20 |
1989-03-20 |
Nordisk Gentofte |
Insulinforbindelser
|
|
US5512459A
(en)
*
|
1993-07-20 |
1996-04-30 |
Bionebraska, Inc. |
Enzymatic method for modification or recombinant polypeptides
|
|
JP2001521006A
(ja)
|
1997-10-24 |
2001-11-06 |
イーライ・リリー・アンド・カンパニー |
不溶性インシュリン組成物
|
|
US6531448B1
(en)
|
1997-12-23 |
2003-03-11 |
Eli Lilly And Company |
Insoluble compositions for controlling blood glucose
|
|
JP4795599B2
(ja)
|
1999-12-29 |
2011-10-19 |
ノボ ノルディスク アクティーゼルスカブ |
酵母において改良された発酵収率を有するインスリン前駆体及びインスリン前駆体類似体の製造方法
|
|
AR025646A1
(es)
*
|
2000-09-13 |
2002-12-04 |
Beta Lab Sa |
Cepa de levaduras metilotroficas recombinantes productoras de un precursor de insulina, construcciones de adn y metodo para obtener la cepa.
|
|
DE60236014D1
(de)
|
2001-11-19 |
2010-05-27 |
Novo Nordisk As |
Verfahren zur herstellung von insulinverbindungen
|
|
US7396903B2
(en)
*
|
2001-11-19 |
2008-07-08 |
Novo Nordisk A/S |
Process for preparing insulin compounds
|
|
UA46667C2
(en)
*
|
2001-12-29 |
2006-01-16 |
Omakooe Ltd Liability Company |
Method for preparing semisynthetic human insulin
|
|
US7279457B2
(en)
*
|
2004-03-12 |
2007-10-09 |
Biodel, Inc. |
Rapid acting drug delivery compositions
|
|
US20080090753A1
(en)
|
2004-03-12 |
2008-04-17 |
Biodel, Inc. |
Rapid Acting Injectable Insulin Compositions
|
|
US20080085298A1
(en)
*
|
2004-03-12 |
2008-04-10 |
Biodel, Inc. |
Rapid Mucosal Gel or Film Insulin Compositions
|
|
US20080096800A1
(en)
*
|
2004-03-12 |
2008-04-24 |
Biodel, Inc. |
Rapid mucosal gel or film insulin compositions
|
|
CA2608311C
(en)
|
2005-05-13 |
2012-11-27 |
Eli Lilly And Company |
Glp-1 pegylated compounds
|
|
PL1907419T3
(pl)
*
|
2005-07-08 |
2011-08-31 |
Biocon Ltd |
Wytwarzanie koniugatów insuliny
|
|
US7713929B2
(en)
*
|
2006-04-12 |
2010-05-11 |
Biodel Inc. |
Rapid acting and long acting insulin combination formulations
|
|
US8084420B2
(en)
*
|
2005-09-29 |
2011-12-27 |
Biodel Inc. |
Rapid acting and long acting insulin combination formulations
|
|
EP2012817A2
(en)
*
|
2006-04-12 |
2009-01-14 |
Biodel, Inc. |
Rapid acting and long acting insulin combination formulations
|
|
JP2009534423A
(ja)
|
2006-04-20 |
2009-09-24 |
アムジェン インコーポレイテッド |
Ｇｌｐ−１化合物
|
|
WO2008124522A2
(en)
*
|
2007-04-04 |
2008-10-16 |
Biodel, Inc. |
Amylin formulations
|
|
EP2234644B1
(en)
*
|
2008-01-04 |
2013-07-31 |
Biodel, Inc. |
Insulin formulations for insulin release as a function of tissue glucose levels
|
|
LT2314609T
(lt)
|
2008-07-30 |
2017-04-10 |
Takeda Pharmaceutical Company Limited |
Metastino darinys ir jo panaudojimas
|
|
US9060927B2
(en)
|
2009-03-03 |
2015-06-23 |
Biodel Inc. |
Insulin formulations for rapid uptake
|
|
US8618049B2
(en)
|
2009-09-08 |
2013-12-31 |
Stephen B. H. Kent |
Ester insulin
|
|
KR20130036290A
(ko)
|
2010-06-23 |
2013-04-11 |
노보 노르디스크 에이/에스 |
추가 이황화 결합을 함유하는 인슐린 유도체
|
|
JP5973427B2
(ja)
|
2010-06-23 |
2016-08-23 |
ノヴォ ノルディスク アー／エス |
追加のジスルフィド結合を含有するインスリン類似体
|
|
WO2011161083A1
(en)
|
2010-06-23 |
2011-12-29 |
Novo Nordisk A/S |
Human insulin containing additional disulfide bonds
|
|
JP2014509603A
(ja)
|
2011-03-15 |
2014-04-21 |
ノヴォ ノルディスク アー／エス |
システイン置換を含むヒトインスリン類似体およびヒトインスリン誘導体
|
|
CN103596584B
(zh)
|
2011-06-15 |
2016-12-14 |
诺沃—诺迪斯克有限公司 |
多取代的胰岛素
|
|
US9707276B2
(en)
|
2012-12-03 |
2017-07-18 |
Merck Sharp & Dohme Corp. |
O-glycosylated carboxy terminal portion (CTP) peptide-based insulin and insulin analogues
|
|
JP2016521701A
(ja)
|
2013-06-07 |
2016-07-25 |
ノヴォ ノルディスク アー／エス |
成熟インスリンポリペプチドを作製するための方法
|
|
CN105849273B
(zh)
*
|
2013-12-23 |
2020-01-14 |
拜康研究有限公司 |
人胰岛素甲酯的生产方法
|
|
US10919949B2
(en)
|
2017-08-17 |
2021-02-16 |
Novo Nordisk A/S |
Acylated insulin analogues and uses thereof
|
|
WO2023144240A1
(en)
|
2022-01-26 |
2023-08-03 |
Novo Nordisk Research Centre Oxford Limited |
Glucose sensitive insulin derivatives and uses thereof
|